PILIEF OINTMENT

Indications

• Respiratory conditions (e.g., asthma, bronchitis)
• Fever
• Fatigue
• General tonic for energy enhancement
• Diuretic for fluid retention

Dosage

Children: Paediatric dosing should be determined by a healthcare professional, considering the child's age, weight, and clinical condition. Always refer to specific guidelines for paediatric use.

Adults: Dosage varies depending on the form of chaal used and clinical indication. Refer to specific product guidelines for precise dosing recommendations.

Mechanism of action

The active compounds in chaal, such as ephedrine and other alkaloids, are believed to act as sympathomimetic agents. They stimulate alpha-adrenergic and beta-adrenergic receptors, leading to increased heart rate, bronchodilation, and vasoconstriction. This results in improved airflow in the respiratory tract and increased blood circulation.

Pharmacodynamics

Chaal exhibits a range of pharmacodynamic effects including increased cardiovascular activity, enhanced respiratory function, and modulation of immune responses. The herb's diuretic properties may also contribute to its overall health benefits by promoting fluid balance and reducing swelling.

Pharmacokinetics

The pharmacokinetics of chaal are not extensively studied, but it is known that the active ingredients are absorbed in the gastrointestinal tract. The half-life, metabolism, and excretion pathways remain largely undefined in clinical settings. The onset of action can vary, generally appearing within 30 minutes after administration, with effects lasting for several hours.

Pregnancy

There is limited data on the safety of chaal during pregnancy. It is recommended to use caution and consult a healthcare professional before use.

Breast-feeding

The safety of chaal during breastfeeding is not well established. Nursing mothers should consult a healthcare provider prior to use.

Storage

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Indications

• Anti-inflammatory conditions
• Osteoarthritis
• Rheumatoid arthritis
• Digestive disorders
• Skin conditions
• Metabolic syndrome

Dosage

Adults: There is no standard dosage for haldi as it depends on the form used (powder, capsules, etc.) and the intended purpose. General guidance suggests 400-600 mg of curcumin

Mechanism of action

Curcumin, the active ingredient in haldi, exerts its effects through multiple mechanisms, including the modulation of various signaling pathways. It inhibits nuclear factor kappa B (NF-κB), a transcription factor that plays a crucial role in inflammatory responses. Curcumin also affects the activity of various enzymes and receptors, including cyclooxygenase-2 (COX-2) and lipoxygenase, which are involved in inflammation. Additionally, curcumin has been shown to influence the expression of various genes related to inflammation and oxidative stress.

Pharmacodynamics

Haldi has demonstrated a range of pharmacological effects, primarily attributed to its anti-inflammatory and antioxidant properties. It can help reduce inflammation by inhibiting pro-inflammatory cytokines and enzymes. Curcumin's antioxidant activity helps neutralize free radicals, reducing oxidative stress and preventing cellular damage. Furthermore, it may have a potential role in modulating metabolic processes, enhancing insulin sensitivity, and supporting cardiovascular health.

Pharmacokinetics

Curcumin has low bioavailability due to its poor absorption in the gastrointestinal tract, rapid metabolism, and systemic elimination. It is primarily metabolized in the liver and intestines, resulting in the formation of various metabolites. The peak plasma concentration of curcumin occurs approximately 1-2 hours after oral administration, but due to its rapid clearance, its effects may be short-lived. Co-administration with substances like black pepper (which contains piperine) has been shown to enhance curcumin absorption significantly.

Contra-indications

• Hypersensitivity to curcumin or any of the excipients
• Biliary obstruction
• Gallbladder disorders

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Allergic skin reactions
• Increased risk of bleeding

Interactions

• Anticoagulants and antiplatelet drugs (may increase bleeding risk)
• Drugs that lower blood sugar (may enhance hypoglycemic effect)
• Proton pump inhibitors (may alter absorption)

Precautions

• Use with caution in patients with gallstones or bile duct obstruction
• Monitor for signs of bleeding in patients on anticoagulant therapy
• Use cautiously in pregnant women and those with liver disease

Pregnancy

Limited data on safety, use only if potential benefits justify the risks.

Breast-feeding

Considered safe in small amounts, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered form
• Capsules
• Liquid extracts
• Tea

Indications

• Diarrhea
• Dysentery
• Skin infections
• Inflammatory bowel disease
• Sore throat
• Mouth ulcers

Dosage

Children: Refer to established guidelines and consult with a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines and consult with a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in Khair, particularly catechins, exhibit antioxidant properties that can scavenge free radicals. These compounds may also inhibit the growth of certain bacteria and fungi, thereby exerting antimicrobial effects. Additionally, catechins can promote vasodilation and improve blood flow, contributing to their therapeutic effects.

Pharmacodynamics

Khair demonstrates a range of pharmacological effects, including anti-inflammatory, antimicrobial, and astringent actions. Its astringent properties make it effective in reducing secretions and promoting tissue contraction, which is beneficial in gastrointestinal disorders. The anti-inflammatory effects can help alleviate symptoms associated with inflammatory conditions.

Pharmacokinetics

The pharmacokinetics of Khair have not been extensively studied. However, it is believed that the active compounds are absorbed in the gastrointestinal tract and may undergo hepatic metabolism before exerting their systemic effects. The duration of action and elimination half-life are not well-defined and would depend on the specific formulation and route of administration.

Pregnancy

There is limited information on the safety of khair during pregnancy. It is advisable to avoid use unless the benefits outweigh potential risks.

Breast-feeding

Insufficient data is available regarding the use of khair during breastfeeding. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Ensure it is kept out of reach of children.

Indications

• Respiratory issues
• Digestive disturbances
• Anti-inflammatory purposes
• Immune support

Dosage

Children: Specific dosing information for paediatric use is not available. It is advisable to refer to relevant herbal medicine guidelines or consult with a healthcare professional.

Adults: Specific dosing information for adults is not available. It is advisable to refer to relevant herbal medicine guidelines or consult with a healthcare professional.

Mechanism of action

The exact mechanism of action of Kunvar is not well defined in scientific literature. However, it is believed that the herbal components may exert anti-inflammatory, antioxidant, and antimicrobial effects, contributing to its therapeutic properties. These activities are thought to involve modulation of various cellular signaling pathways and inhibition of pro-inflammatory cytokines.

Pharmacodynamics

Pharmacodynamics of Kunvar may involve the interaction of its active components with specific receptors or enzymes in the body, leading to physiological changes. Common effects may include reduction in inflammation, enhancement of immune responses, and improvement in digestive health. However, due to variable composition, the pharmacodynamic profile can differ widely between formulations.

Pharmacokinetics

The pharmacokinetics of Kunvar is not well characterized due to a lack of comprehensive studies. Absorption, distribution, metabolism, and excretion can vary significantly based on the herbal formulation and individual patient factors. Generally, herbal remedies may have variable bioavailability and their effects can be influenced by factors such as age, diet, and concurrent medications.

Pregnancy

The safety of Kunvar during pregnancy has not been established. Use only if the potential benefit justifies the risk to the fetus.

Breast-feeding

Caution is advised when using Kunvar during breastfeeding. Consult a healthcare professional before use.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Acne
• Psoriasis
• Eczema
• Diabetes management
• Dental health (gingivitis, plaque)
• Antimicrobial treatment
• Anti-inflammatory conditions
• Fungal infections

Dosage

Children: Dosage for children is not well established. Refer to specific product guidelines and consult a healthcare professional for appropriate dosing.

Adults: Dosage varies based on the form of neem used (e.g., oil, powder, extract). Commonly, neem oil is applied topically, while neem powder may be taken orally. Refer to specific product guidelines for dosing recommendations.

Mechanism of action

Neem exhibits its effects through multiple bioactive compounds, including azadirachtin, nimbidin, and nimbin. These compounds interact with various biological pathways, such as inhibiting the synthesis of prostaglandins, modulating immune responses, and exhibiting cytotoxic effects on cancer cells. Neem's antifungal and antibacterial activities are attributed to its ability to disrupt microbial cell structures.

Pharmacodynamics

The pharmacodynamics of neem involve its interaction with various cellular pathways, leading to anti-inflammatory, antipyretic, and analgesic effects. Neem's bioactive compounds can reduce oxidative stress and modulate immune responses by influencing cytokine production. Additionally, neem has been shown to inhibit the growth of pathogens through mechanisms such as disrupting cell wall integrity and interfering with nucleic acid synthesis.

Pharmacokinetics

The pharmacokinetics of neem are not fully characterized; however, it is known that the bioactive compounds are absorbed through the gastrointestinal tract when ingested. The metabolism of neem components may occur in the liver, and elimination is primarily through urine and feces. The half-life of neem's active compounds varies, depending on the specific substance and mode of administration.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Stomach upset
• Skin rash
• Allergic reactions

Precautions

• Should be used with caution in individuals with kidney disorders
• Use with caution in pregnant and breastfeeding women
• May lower blood sugar levels, caution in diabetic patients

Pregnancy

Use during pregnancy is not recommended due to potential adverse effects on the fetus.

Breast-feeding

Use during breastfeeding is not recommended as safety has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Neem oil
• Neem leaf extract
• Neem powder
• Neem capsules

Dosage

Children: There is no established clinical dosing regimen for paan in children, and its use is not recommended in pediatric populations due to health risks.

Adults: There is no established clinical dosing regimen for paan, as it is typically consumed in a traditional context rather than as a prescribed medication. Users should be aware of the health risks associated with its consumption.

Mechanism of action

The primary active ingredient in areca nut, arecoline, acts as a muscarinic acetylcholine receptor agonist, leading to increased stimulation of the central nervous system. The combination of betel leaf and areca nut can also enhance the release of dopamine and norepinephrine, contributing to the stimulating effects experienced by users.

Pharmacodynamics

Paan has stimulant properties due to the interaction of its components with the central nervous system. Areca nut can produce effects similar to those of nicotine, including increased alertness and euphoria. However, repeated use is associated with adverse effects such as dependence and an increased risk of oral and esophageal cancers. The vasodilatory effects of certain ingredients may also contribute to its stimulating properties.

Pharmacokinetics

After chewing, the active compounds are rapidly absorbed through the oral mucosa, leading to quick onset of effects. The metabolism of arecoline primarily occurs in the liver, and its elimination half-life is relatively short, necessitating frequent use to maintain effects. The pharmacokinetic profile can be influenced by the presence of other ingredients and the individual's metabolic rate.

Contra-indications

• Hypersensitivity to any component of the product
• Pregnancy
• History of cardiovascular disease

Adverse effects

• Nausea
• Vomiting
• Dizziness
• Headache
• Increased heart rate
• Dry mouth
• Insomnia

Interactions

• May interact with medications that affect the cardiovascular system
• Potential interactions with central nervous system stimulants

Precautions

• Use with caution in patients with cardiovascular conditions
• Monitor for potential dependency with prolonged use
• Caution in patients with liver or kidney impairment

Pregnancy

Not recommended due to potential risks to the fetus.

Breast-feeding

Use with caution, as effects on the nursing infant are not well studied.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Chewing tobacco
• Paan leaves with areca nut
• Paan masala with various flavorings

Indications

• Pain relief
• Anti-inflammatory therapy
• Management of fever

Dosage

Children: Consult a healthcare professional for specific dosing guidelines based on preparation and condition.

Adults: Consult a healthcare professional for specific dosing guidelines based on preparation and condition.

Mechanism of action

The active compounds in patha may exert their effects through various pathways, including the inhibition of cyclooxygenase enzymes, leading to decreased synthesis of prostaglandins, which are mediators of inflammation and pain. Additionally, some compounds may modulate the release of neurotransmitters, further contributing to analgesic effects.

Pharmacodynamics

Patha's pharmacodynamic profile is characterized by its ability to reduce pain and inflammation. The anti-inflammatory effects are likely mediated by the inhibition of inflammatory cytokines and the modulation of immune responses. The analgesic effects may involve central and peripheral mechanisms, affecting pain perception and transmission.

Pharmacokinetics

The pharmacokinetics of patha are not well-characterized due to variability in its preparation and composition. However, it is generally assumed that the active constituents are absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via the kidneys. The onset of action and duration may vary widely based on the formulation and dosage.

Pregnancy

There is limited data on the safety of patha during pregnancy. It is advisable to consult healthcare professionals before use.

Breast-feeding

Caution is advised when using patha while breastfeeding, as safety in lactating women has not been established.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Indications

• Respiratory infections
• Sore throat
• Cough
• Gastroesophageal reflux disease (GERD)
• Peptic ulcers
• Adrenal insufficiency

Dosage

Children: Refer to established paediatric dosing guidelines or consult

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing based on the specific indication and formulation.

Mechanism of action

Glycyrrhizin inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, which leads to increased levels of cortisol. This results in enhanced glucocorticoid activity. Additionally, it exhibits anti-inflammatory effects by inhibiting the production of cytokines and other inflammatory mediators. Yashtimadhu also has mucoprotective and expectorant properties, enhancing mucus secretion and facilitating the clearance of respiratory secretions.

Pharmacodynamics

Yashtimadhu exhibits various pharmacodynamic effects, including anti-inflammatory, antiviral, and antioxidant activities. It acts as a demulcent, providing a protective coating to irritated mucous membranes. Its expectorant properties promote productive cough by stimulating mucus secretion and reducing viscosity. The modulation of immune response and reduction of inflammatory cytokines further contribute to its therapeutic effects.

Pharmacokinetics

The pharmacokinetics of Yashtimadhu are influenced by its active constituents. Glycyrrhizin is absorbed in the gastrointestinal tract and metabolized in the liver. It has a half-life of approximately 6 to 8 hours. The bioavailability of glycyrrhizin may be affected by food intake. It is primarily excreted in the urine as both intact compound and metabolites. Long-term use can lead to potential accumulation and side effects, necessitating caution in dosing.

Pregnancy

Yashtimadhu (Glycyrrhiza glabra) is generally considered safe in pregnancy when used in moderation. However, excessive consumption may lead to potential complications such as hypertension and fluid retention. Consultation with a healthcare provider is recommended.

Breast-feeding

Yashtimadhu is typically regarded as safe during breastfeeding, but it is advisable to use it in moderation. There is limited evidence on its effects during lactation, so consulting a healthcare provider is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried root powder
• Extracts (liquid and powdered)
• Teas
• Capsules